Bausch + Lomb Eye Products Ltd.
GPTKB entity
Statements (40)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:Company
|
gptkbp:acquired_by |
gptkb:Valeant_Pharmaceuticals
|
gptkbp:acquisition_year |
gptkb:2013
|
gptkbp:employees |
Over 10,000
|
gptkbp:founded_in |
1853
|
gptkbp:founder |
John Bausch
|
gptkbp:headquarters |
gptkb:Rochester,_New_York
|
https://www.w3.org/2000/01/rdf-schema#label |
Bausch + Lomb Eye Products Ltd.
|
gptkbp:industry |
Healthcare
|
gptkbp:parent_company |
gptkb:Bausch_Health_Companies
|
gptkbp:products |
gptkb:cream
gptkb:sunglasses |
gptkbp:region |
Global
|
gptkbp:revenue |
$3 billion (2020)
|
gptkbp:specialization |
Ophthalmic products
|
gptkbp:subsidiaries |
gptkb:Bausch_+_Lomb_Australia
gptkb:Bausch_+_Lomb_UK gptkb:Bausch_+_Lomb_Canada gptkb:Bausch_+_Lomb_India |
gptkbp:trademark |
gptkb:Vigamox
gptkb:Boston gptkb:Systane gptkb:Bepreve gptkb:Durezol gptkb:Lotemax gptkb:Ultraman gptkb:Biofinity gptkb:Pure_Vision Ocuvite Artelac Lotemax SM Prolensa Soothe Renu Zylet Lacri-Lube Alrex |
gptkbp:website |
www.bausch.com
|
gptkbp:bfsParent |
gptkb:Bausch_&_Lomb
|
gptkbp:bfsLayer |
5
|